|
NIG-RNAi Strains Detail |
Request : Click the "Order" button to request for this stock |
|
Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
Stock ID |
11466R-3 |
Symbol |
Cyp9f2 |
Full Name |
Cyp9f2 |
CG No |
CG11466 |
Old CG No |
CG11466 |
Synonyms |
9f2, anon-EST:Posey150, CG11466, Cyp9f2 |
Accession No (Link to NCBI) |
NM_141932.2 |
Inserted Chr. |
ll |
Insertional Mutation |
|
Phenotype induced by Act5C-GAL4 at 28 degrees |
viable |
Map Viewer |
|
Reference
[Please submit your publication]
|
Dourlen P, Fernandez-Gomez FJ, Dupont C, Grenier-Boley B, Bellenguez C, Obriot H, Caillierez R, Sottejeau Y, Chapuis J, Bretteville A, Abdelfettah F, Delay C, Malmanche N, Soininen H, Hiltunen M, Galas MC, Amouyel P, Sergeant N, Buée L, Lambert JC, Dermaut B. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology. Mol Psychiatry (2017) 22(6) 874-883
[
PubMed ID = 27113998
]
[
RRC reference
]
|
Comment |
|
Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
Primer Seq. 5' |
aaggcctacatggccggaccgAGGAGGCCGTGGACTGTCTTA |
Primer Seq. 3' |
aatctagaggtaccGAAGCACATCAGCACCGCCGA |
Predicted Fragment Size |
500 |
IR fragment full Seq |
0001 AGGAGGCCGT GGACTGTCTT AAGCAGGATG ATTCAAGGGT TCAGGAGAAT GAACTGGACA
0061 TGAAGGACTA CTGCACACGA TTCACCAATG ATGTGATCGC CTCGACAGCC TTTGGACTGC
0121 AAGTGAACTC GTTCAAGGAT CGCGAAAATA CCTTCTATCA GATGGGAAAA AAGCTGACCA
0181 CATTTACATT CCTGCAGAGC ATGNAAGTTC ATGTTGTTCT TCGCATTGAA GGGTCTTAAT
0241 AAGATCCTTA AGGTCGAGCT TTTCGATAGG AAAAGCACTC AGTATTTCGT GCGTCTGGTG
0301 CTCGATGCTA TGAAATACCG ACAGGAGCAC AATATTGTAC GTCCCGACAT GATAAACATG
0361 CTGATGGAGG CTCGTGGTAT CATCCAGACG GAGAAGACCA AGGCATCTGC CGTTCGCGAG
0421 TGGAGCGAtN GCGACATTGT CGCCCAGTGT TTCGTGTTCT TCTTTGCTGG CTTCGAGACT
0481 TCGGNGGTGC TGATGTGCTT C |
in silico PCR Fragment |
0001 AGGAGGCCGT GGACTGTCTT AAGCAGGATG ATTCAAGGGT TCAGGAGAAT GAACTGGACA
0061 TGAAGGACTA CTGCACACGA TTCACCAATG ATGTGATCGC CTCGACAGCC TTTGGACTGC
0121 AAGTGAACTC GTTCAAGGAT CGCGAAAATA CCTTCTATCA GATGGGAAAA AAGCTGACCA
0181 CATTTACATT CCTGCAGAGC ATG-AAGTTC ATGTTGTTCT TCGCATTGAA GGGTCTTAAT
0241 AAGATCCTTA AGGTCGAGCT TTTCGATAGG AAAAGCACTC AGTATTTCGT GCGTCTGGTG
0301 CTCGATGCTA TGAAATACCG ACAGGAGCAC AATATTGTAC GTCCCGACAT GATAAACATG
0361 CTGATGGAGG CTCGTGGTAT CATCCAGACG GAGAAGACCA AGGCATCTGC CGTTCGCGAG
0421 TGGAGCGATC GCGACATTGT CGCCCAGTGT TTCGTGTTCT TCTTTGCTGG CTTCGAGACT
0481 TCGGCGGTGC TGATGTGCTT C |
Assemble Data |
11466R-3.IR_full 1 AGGAGGCCGTGGACTGTCTTAAGCAGGATGATTCAAGGGTTCAGGAGAATGAACTGGACA 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11466R-3.in silico 1 AGGAGGCCGTGGACTGTCTTAAGCAGGATGATTCAAGGGTTCAGGAGAATGAACTGGACA 60
11466R-3.IR_full 61 TGAAGGACTACTGCACACGATTCACCAATGATGTGATCGCCTCGACAGCCTTTGGACTGC 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11466R-3.in silico 61 TGAAGGACTACTGCACACGATTCACCAATGATGTGATCGCCTCGACAGCCTTTGGACTGC 120
11466R-3.IR_full 121 AAGTGAACTCGTTCAAGGATCGCGAAAATACCTTCTATCAGATGGGAAAAAAGCTGACCA 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11466R-3.in silico 121 AAGTGAACTCGTTCAAGGATCGCGAAAATACCTTCTATCAGATGGGAAAAAAGCTGACCA 180
11466R-3.IR_full 181 CATTTACATTCCTGCAGAGCATGNAAGTTCATGTTGTTCTTCGCATTGAAGGGTCTTAAT 240
||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||
11466R-3.in silico 181 CATTTACATTCCTGCAGAGCATG-AAGTTCATGTTGTTCTTCGCATTGAAGGGTCTTAAT 240
11466R-3.IR_full 241 AAGATCCTTAAGGTCGAGCTTTTCGATAGGAAAAGCACTCAGTATTTCGTGCGTCTGGTG 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11466R-3.in silico 241 AAGATCCTTAAGGTCGAGCTTTTCGATAGGAAAAGCACTCAGTATTTCGTGCGTCTGGTG 300
11466R-3.IR_full 301 CTCGATGCTATGAAATACCGACAGGAGCACAATATTGTACGTCCCGACATGATAAACATG 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11466R-3.in silico 301 CTCGATGCTATGAAATACCGACAGGAGCACAATATTGTACGTCCCGACATGATAAACATG 360
11466R-3.IR_full 361 CTGATGGAGGCTCGTGGTATCATCCAGACGGAGAAGACCAAGGCATCTGCCGTTCGCGAG 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11466R-3.in silico 361 CTGATGGAGGCTCGTGGTATCATCCAGACGGAGAAGACCAAGGCATCTGCCGTTCGCGAG 420
11466R-3.IR_full 421 TGGAGCGATNGCGACATTGTCGCCCAGTGTTTCGTGTTCTTCTTTGCTGGCTTCGAGACT 480
||||||||| ||||||||||||||||||||||||||||||||||||||||||||||||||
11466R-3.in silico 421 TGGAGCGATCGCGACATTGTCGCCCAGTGTTTCGTGTTCTTCTTTGCTGGCTTCGAGACT 480
11466R-3.IR_full 481 TCGGNGGTGCTGATGTGCTTC 501
|||| ||||||||||||||||
11466R-3.in silico 481 TCGGCGGTGCTGATGTGCTTC 501
|
Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
3 |
NM_141932.2 |
CG11466-RA, transcript variant A (Cyp9f2), mRNA |
100 |
482 |
0 |
0 |
3 |
NM_206478.1 |
CG11466-RB, transcript variant B (Cyp9f2), mRNA |
77.59 |
374 |
83 |
25 |
0 |
NR_001369.1 |
CG11466-RB, transcript variant B (Cyp9f2), mRNA, mRNA |
0 |
0 |
2 |
10 |
4 |
NM_079025.3 |
CG10248-RA (Cyp6a8), mRNA |
0 |
0 |
2 |
2 |
4 |
NM_138220.1 |
CG13889-RA (CG13889), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_164914.1 |
CG4995-RB, transcript variant B (CG4995), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_135536.2 |
CG4995-RA, transcript variant A (CG4995), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_164915.1 |
CG4995-RC, transcript variant C (CG4995), mRNA |
0 |
0 |
1 |
10 |
4 |
NR_001388.1 |
CG4995-RC, transcript variant C (CG4995), mRNA, mRNA |
0 |
0 |
1 |
4 |
4 |
NM_168610.1 |
CG13457-RA, transcript variant A (CG13457), mRNA |
0 |
0 |
1 |
4 |
4 |
NM_140494.1 |
CG13457-RB, transcript variant B (CG13457), mRNA |
0 |
0 |
1 |
3 |
4 |
NM_141163.1 |
CG11226-RA (CG11226), mRNA |
0 |
0 |
1 |
3 |
3 |
NM_079430.2 |
CG6818-RA (MESR6), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_001015498.1 |
CG40446-PA (CG40446), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_001042852.1 |
CG12500-RB, transcript variant B (stnA), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_001042853.1 |
CG12473-RA, transcript variant A (stnB), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_001042854.1 |
CG12473-RB, transcript variant B (stnB), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_001042851.1 |
CG12500-RA, transcript variant A (stnA), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_080359.3 |
CG11822-RA, transcript variant A (nAcRbeta-21C), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_164386.2 |
CG11822-RB, transcript variant B (nAcRbeta-21C), mRNA |
0 |
0 |
0 |
11 |
39 |
NM_136976.1 |
CG17577-RA (Cyp9h1), mRNA |
0 |
0 |
0 |
6 |
4 |
NM_176309.2 |
CG33205-RC, transcript variant C (CG33205), mRNA |
0 |
0 |
0 |
6 |
4 |
NM_176311.2 |
CG33205-RG, transcript variant G (CG33205), mRNA |
0 |
0 |
0 |
6 |
4 |
NM_176308.2 |
CG33205-RB, transcript variant B (CG33205), mRNA |
0 |
0 |
0 |
6 |
4 |
NM_001038908.1 |
CG33205-RH, transcript variant H (CG33205), mRNA |
0 |
0 |
0 |
6 |
4 |
NM_176310.2 |
CG33205-RF, transcript variant F (CG33205), mRNA |
0 |
0 |
0 |
6 |
3 |
NM_140913.1 |
CG7668-RA, transcript variant A (CG7668), mRNA |
0 |
0 |
0 |
6 |
3 |
NM_168830.1 |
CG7668-RB, transcript variant B (CG7668), mRNA |
0 |
0 |
0 |
4 |
16 |
NM_079126.2 |
CG3616-RA (Cyp9c1), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_140465.2 |
CG9311-RA (CG9311), mRNA |
|
|
|